Novel gene silencing therapy for cervical cancer
20th Nov 2005, 11:51 GMT
Sydney: A team of researchers at The University of Queensland's (UQ) Centre for Immunology and Cancer Research (CICR) has pioneered a new gene silencing therapy for the treatment of cervical cancer, which is the leading cause of cancer death in women aged 25-50 worldwide.
Novel gene silencing therapy for cervical cancer related news:
- Novel gene silencing therapy for cervical cancer — KeralaNext: Health
- New approach for the treatment of cervical cancer - New gene silencing therapy — Medical News Today RSS/XML Feed
- New Gene Silencing Therapy For Cervical Cancer — ScienceDaily Headlines
- Women Still at Cervical Cancer Risk After CIN Therapy — MedPage Today Hematology/Oncology
- Hypoxia- and radiation-activated Cre/loxP ‘molecular switch’ vectors for gene therapy of cancer — Gene Therapy
- Scottish women, who have high incidence of cervical cancer, given vaccine — The Cancer Blog
- Cervical cancer shots win some conservative favor (Reuters) —
- Scots teenagers first to test cervical cancer vaccine — Scotsman.com News
- Cervical cancer cells warning — Scotsman.com News - UK
- Radiation Therapy Increases Hip and Other Pelvic Fracture Risk — MedPage Today Hematology/Oncology
Latest news from Health News:
- Turning off the TV can make your kids healthy!
- Red meat linked to increased breast cancer risk
- Snail toxins can help relieve severe nerve pain
- Red meat intake linked to breast cancer risk
- Depression not anti-depressants leads to death
- What you eat will reflect in your grandchildren
- Novel vaccine shows promise against early-stage breast cancer
- New test raises hope for early detection of blocked arteries
- Acupuncture helps ease discomfort in rheumatoid arthritis patients
- Late-life pregnancies risky, but births are good: study